증례

혈액 투석 중 양측 돌발성 난청이 순차적으로 발생한 만성신부전 환자 1예

김세형1, 임길채1, 최승효1,*
Se-Hyung Kim1, Gil Chai Lim1, Seung Hyo Choi1,*
Author Information & Copyright
1제주대학교 의과대학 이비인후과학교실
1Department of Otorhinolaryngology-Head and Neck Surgery, Jeju National University School of Medicine, Jeju, Korea
*교신저자: 최승효,690-767 제주특별자치도 제주시 아란 13길 15 제주대학교 의과대학 이비인후과학교실 전화:(064) 64-717-1837·전송:(064) 717-1131 E-mail: photen27@naver.com

© Copyright 2012 The Busan, Ulsan, Gyeoungnam Branch of Korean Society of Otolaryngology-Head and Neck Surgery. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Mar 30, 2012; Revised: Apr 19, 2012; Accepted: May 14, 2012

Published Online: May 31, 2020

ABSTRACT

Hemodialysis (HD) is a valid treatment modality in patients with chronic renal failure (CRF). Both CRF and HD have been noted as a possible cause of tinnitus, vertigo and sensorineural hearing loss (SNHL). There have been many efforts to elucidate the etiologic factors of hearing impairment in patients with CRF who underwent HD. But, it is difficult to explain association between them. Especially, sudden SNHL (SSNHL) in patients with CRF who underwent HD is highly unusual. We report, with a review of literatures bilateral SSNHL associated with CRF and HD as its treatment. At first, patient developed profound SSNHL in right side with benign paroxysmal positional vertigo (BPPV) after HD for 18 months. In spite of the treatment with systemic steroid and intratympanic dexamethasone injection (ITDI) hearing result was poor. And then SSNHL occurred in left side after 6 months. Hearing result was poor. (J Clinical Otolaryngol 2012;23:110–116)

Keywords: 돌발성 난청; 혈액 투석; 만성신부전
Keywords: Sudden hearing loss; Renal dialysis; Chronic kidney failure


임상이비인후과 학술상 공지


안녕하십니까.

대한이비인후과학회 부산울산경남지부회에서는

회원분들의 학술 연구를 장려하는 의미에서 

2022년도부터 학술상을 신설해 수여하고자 합니다. 

 

임상이비인후과 학술상

1. 2022년에 본 학술지에 게재된 논문중

인용횟수 및 학술적 가치가 높은 연구주제에 대해

편집위원회에서 선정 후 수여

2. 수상자는 논문의 교신저자로 함

3. 시상 - 상장 및 상금 50만원

4. 시상일 - 추후 공지

5. 편집위원회에서 선정하므로 별도의 신청 필요 없음

 

- 관련문의 

 임상이비인후과 편집위원회  jco.hns.1990@gmail.com


I don't want to open this window for a day.